Synthesis and Biological Evaluation of Halogenated Phenoxychalcones and Their Corresponding Pyrazolines As Cytotoxic Agents in Human Breast Cancer

Overview

Journal J Enzyme Inhib Med Chem

Specialty Biochemistry

Date 2021 Dec 13

PMID 34894967

Citations 4

Authors

Peter A Halim

Rasha A Hassan

Khaled O Mohamed

Soha O Hassanin

Mona G Khalil

Amr M Abdou

Eman O Osman

Affiliations

Soon will be listed here.

Abstract

Novel halogenated phenoxychalcones and their corresponding -acetylpyrazolines were synthesised and evaluated for their anticancer activities against breast cancer cell line (MCF-7) and normal breast cell line (MCF-10a), compared with staurosporine. All compounds showed moderate to good cytotoxic activity when compared to control. Compound was the most active, with IC = 1.52 µM and selectivity index = 15.24. Also, chalcone showed significant cytotoxic activity with IC = 1.87 µM and selectivity index = 11.03. Compound decreased both total mitogen activated protein kinase (p38α MAPK) and phosphorylated enzyme in MCF-7 cells, suggesting its ability to decrease cell proliferation and survival. It also showed the ability to induce ROS in MCF-7 treated cells. Compound exhibited apoptotic behaviour in MCF-7 cells due to cell accumulation in G2/M phase and elevation in late apoptosis 57.78-fold more than control. Docking studies showed that compounds and interact with p38alpha MAPK active sites.

Citing Articles

New oxadiazole and pyrazoline derivatives as anti-proliferative agents targeting EGFR-TK: design, synthesis, biological evaluation and molecular docking study.

Serag M, Tawfik S, Badr S, Eisa H Sci Rep. 2024; 14(1):5474.

PMID: 38443456 PMC: 10915170. DOI: 10.1038/s41598-024-55046-0.

Novel pyrazolo[3,4-]pyrimidine derivatives: design, synthesis, anticancer evaluation, VEGFR-2 inhibition, and antiangiogenic activity.

Abdelhamed A, Hassan R, Kadry H, Helwa A RSC Med Chem. 2023; 14(12):2640-2657.

PMID: 38107182 PMC: 10718518. DOI: 10.1039/d3md00476g.

Design and synthesis of novel quinazolinone-based derivatives as EGFR inhibitors with antitumor activity.

Sonousi A, Hassan R, Osman E, Abdou A, Emam S J Enzyme Inhib Med Chem. 2022; 37(1):2644-2659.

PMID: 36146940 PMC: 9518264. DOI: 10.1080/14756366.2022.2118735.

Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights.

Al-Warhi T, El Kerdawy A, Said M, Albohy A, Elsayed Z, Aljaeed N Drug Des Devel Ther. 2022; 16:1457-1471.

PMID: 35607598 PMC: 9123247. DOI: 10.2147/DDDT.S356988.

References

Xue L, Chiu S, Oleinick N . Staurosporine-induced death of MCF-7 human breast cancer cells: a distinction between caspase-3-dependent steps of apoptosis and the critical lethal lesions. Exp Cell Res. 2003; 283(2):135-45. DOI: 10.1016/s0014-4827(02)00032-0. View

Kumar P, Tripathi L . A new class of anticonvulsants possessing 6 Hz psychomotor seizure test activity: 2-(1H-benzotriazol-1-yl)-N'-[substituted] acetohydrazides. Med Chem. 2012; 8(3):337-48. DOI: 10.2174/157340612800786606. View

Acharya A, Das I, Chandhok D, Saha T . Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxid Med Cell Longev. 2010; 3(1):23-34. PMC: 2835886. DOI: 10.4161/oxim.3.1.10095. View

Sashidhara K, Dodda R, Sonkar R, Palnati G, Bhatia G . Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents. Eur J Med Chem. 2014; 81:499-509. DOI: 10.1016/j.ejmech.2014.04.085. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Scudiero D, Shoemaker R, Paull K, Monks A, Tierney S, Nofziger T . Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988; 48(17):4827-33. View

He L, He T, Farrar S, Ji L, Liu T, Ma X . Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species. Cell Physiol Biochem. 2017; 44(2):532-553. DOI: 10.1159/000485089. View

Wei L, Wu J, Li G, Shi N . Cis-enone resorcylic acid lactones (RALs) as irreversible protein kinase inhibitors. Curr Pharm Des. 2012; 18(9):1186-98. DOI: 10.2174/138161212799436395. View

Schmitt F, Draut H, Biersack B, Schobert R . Halogenated naphthochalcones and structurally related naphthopyrazolines with antitumor activity. Bioorg Med Chem Lett. 2016; 26(21):5168-5171. DOI: 10.1016/j.bmcl.2016.09.076. View

10.

Karabacak M, Altintop M, Ciftci H, Koga R, Otsuka M, Fujita M . Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents. Molecules. 2015; 20(10):19066-84. PMC: 6332424. DOI: 10.3390/molecules201019066. View

11.

Ashour H, Abou-Zeid L, El-Sayed M, Selim K . 1,2,3-Triazole-Chalcone hybrids: Synthesis, in vitro cytotoxic activity and mechanistic investigation of apoptosis induction in multiple myeloma RPMI-8226. Eur J Med Chem. 2020; 189:112062. DOI: 10.1016/j.ejmech.2020.112062. View

12.

Singh I, Rani R, Luxami V, Paul K . Synthesis of 5-(4-(1H-phenanthro[9,10-d]imidazol-2-yl)benzylidene)thiazolidine-2,4-dione as promising DNA and serum albumin-binding agents and evaluation of antitumor activity. Eur J Med Chem. 2019; 166:267-280. DOI: 10.1016/j.ejmech.2019.01.053. View

13.

Abdelhafez O, Ahmed E, Abdel Latif N, Arafa R, Abd Elmageed Z, Ali H . Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds. Bioorg Med Chem. 2019; 27(7):1308-1319. DOI: 10.1016/j.bmc.2019.02.027. View

14.

Baell J, Holloway G . New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem. 2010; 53(7):2719-40. DOI: 10.1021/jm901137j. View

15.

Kassab A, Gedawy E, A Hamed M, Doghish A, Hassan R . Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers. J Enzyme Inhib Med Chem. 2021; 36(1):922-939. PMC: 8079033. DOI: 10.1080/14756366.2021.1901089. View

16.

Simmler C, Lankin D, Nikolic D, van Breemen R, Pauli G . Isolation and structural characterization of dihydrobenzofuran congeners of licochalcone A. Fitoterapia. 2017; 121:6-15. PMC: 5660606. DOI: 10.1016/j.fitote.2017.06.017. View

17.

Yang S, Huang Z, Zhou Z, Hou J, Zheng M, Wang L . Structure-based design, structure-activity relationship analysis, and antitumor activity of diaryl ether derivatives. Arch Pharm Res. 2015; 38(10):1761-73. DOI: 10.1007/s12272-015-0578-7. View

18.

Bilginer S, Gul H, Erdal F, Sakagami H, Gulcin I . New halogenated chalcones with cytotoxic and carbonic anhydrase inhibitory properties: 6-(3-Halogenated phenyl-2-propen-1-oyl)-2(3H)-benzoxazolones. Arch Pharm (Weinheim). 2020; 353(6):e1900384. DOI: 10.1002/ardp.201900384. View

19.

Goksen U, Sarigul S, Bultinck P, Herrebout W, Dogan I, Yelekci K . Absolute configuration and biological profile of pyrazoline enantiomers as MAO inhibitory activity. Chirality. 2018; 31(1):21-33. DOI: 10.1002/chir.23027. View

20.

Emam S, Sonousi A, Osman E, Hwang D, Kim G, Hassan R . Design and synthesis of methoxyphenyl- and coumarin-based chalcone derivatives as anti-inflammatory agents by inhibition of NO production and down-regulation of NF-κB in LPS-induced RAW264.7 macrophage cells. Bioorg Chem. 2021; 107:104630. DOI: 10.1016/j.bioorg.2021.104630. View